Indonesia to provide 28m vaccine doses against foot, mouth disease
Foreign
A total of 28 million doses of vaccines will be provided for livestock across Indonesia in a bid to overcome the re-emergence of the deadly foot-and-mouth disease (FMD).
Airlangga Hartarto, Coordinating Minister for Economic Affairs said on Wednesday that the budget for the livestock vaccination campaign is being prepared.
He said the government has imported at least three million vaccine doses and distributed them to the worst affected regions.
“We will continue to increase the number up to 28 million vaccine doses.
“ Healthy animals will be vaccinated while sick ones will treated,” said the minister.
As of Tuesday, the viral disease has spread across 208 municipalities in 19 provinces.
According to official data from the National FMD Task Force, more than 210,000 animals were reportedly infected and at least 1,266 animals died from the disease.
More than 67,000 animals have recovered as the authorities deployed thousands of veterinary paramedics and distributed medicines, antibiotics, vitamins, immune boosters as well as disinfecting agents to livestock farmers.
Meanwhile, 1,571 livestock animals have been vaccinated with the imported vaccines.
The Agriculture Ministry is currently developing its own vaccines to overcome the crisis.
It said the vaccine will be ready in late July or late August. (Xinhua/NAN)
– June 22, 2022 @ 13:50 GMT | AI.
Related Posts
Israeli court delays corruption hearings with Netanyahu in hospital
THE Jerusalem court hearing Israeli Prime Minister Benjamin Netanyahu’s corruption trial has postponed hearings set for next week as Netanyahu...
Read MoreSyria’s interim govt to disband al-Assad’s security agencies
SYRIA’s transitional government has vowed to dissolve and restructure all security agencies of the toppled dictator Bashar al-Assad’s regime accused...
Read MoreUK channel migrant crossings hit 150,000 since 2018
MORE than 150,000 migrants have arrived in the UK after crossing the Channel in the last seven years. Since the...
Read MoreMost Read
Subscribe to Our Newsletter
Keep abreast of news and other developments from our website.